Equipment, Utilities & Facility Qualification (IQ/OQ/PQ)
Third Party and CMO Utility Qualification Oversight for Contract Manufacturers Third Party and CMO Utility Qualification Oversight for Contract Manufacturers The qualification of contract manufacturing organizations (CMOs) and their associated utilities remains an essential component of compliance in the pharmaceutical industry. Regulatory authorities such as the US FDA, EMA, and MHRA expect sponsors to have robust oversight mechanisms in place…
Change Control and Requalification Triggers for Utilities and HVAC Systems Change Control and Requalification Triggers for Utilities and HVAC Systems In the highly regulated pharmaceutical industry, managing and ensuring the consistency of utilities and HVAC systems is paramount for compliance with Good Manufacturing Practices (cGMP). Regulatory authorities, including the US FDA, EMA, MHRA, and PIC/S, provide guidelines that outline validation…
Data Integrity for Utility Monitoring Systems and Building Management Systems Data Integrity for Utility Monitoring Systems and Building Management Systems Introduction to Regulatory Framework In the pharmaceutical industry, ensuring data integrity across utility monitoring systems is paramount for compliance with regulatory expectations. Regulatory agencies, including the FDA, the EMA, and the MHRA, emphasize stringent controls to ensure reliable data management…
Utility Impact Assessments During Facility Expansions and New Equipment Projects Utility Impact Assessments During Facility Expansions and New Equipment Projects Introduction to Utility Impact Assessments In the realm of pharmaceutical manufacturing, utility impact assessments play a crucial role in ensuring that facility expansions and new equipment projects are compliant with regulatory standards. These assessments evaluate the capacity, efficiency, and reliability…
Emergency Response Planning for Utility and HVAC Failures in GMP Facilities Emergency Response Planning for Utility and HVAC Failures in GMP Facilities In the realm of Good Manufacturing Practice (GMP) in the pharmaceutical industry, emergency response planning for utility and HVAC failures is critical to ensure uninterrupted operations, maintain product quality, and comply with regulatory expectations. The potential impacts of…
KPIs and Dashboards for Utility Performance and Qualification Status In the pharmaceutical industry, validation of utilities is a critical aspect that ensures compliance with cGMP and regulatory standards set forth by authorities such as the US FDA, EMA, MHRA, and PIC/S. This article explores the regulatory expectations surrounding utility performance dashboards and key performance indicators (KPIs) utilized to monitor and…
Periodic Review Programs for Qualified Equipment Risk Based Frequencies and Scope Periodic Review Programs for Qualified Equipment Risk Based Frequencies and Scope The pharmaceutical industry operates under stringent regulatory expectations that necessitate a robust approach to validating not only processes but also equipment within manufacturing environments. Periodic Reviews of qualified equipment are essential to ensure ongoing compliance and operational excellence….
Template Periodic Review Reports for Equipment and Utility Qualification Status Template Periodic Review Reports for Equipment and Utility Qualification Status In the regulated pharmaceutical industry, maintaining the qualification status of equipment and utilities is crucial to ensure compliance with current Good Manufacturing Practices (cGMP). A structured and thorough periodic review is essential for assessing the performance and continued suitability of…
Change Control Strategies for Qualified Equipment Minimising Revalidation Overkill Change Control Strategies for Qualified Equipment Minimising Revalidation Overkill Introduction to Change Control in Pharmaceutical Validation Change control is a critical aspect of pharmaceutical validation that ensures any modifications to qualified equipment do not adversely affect product quality or patient safety. Regulatory bodies such as the US FDA, EMA, and MHRA…
Audit Ready Evidence for Periodic Review Programs and Lifecycle Management Audit Ready Evidence for Periodic Review Programs and Lifecycle Management Introduction to Evidence for Periodic Review Programs In the pharmaceutical industry, maintaining compliance with Good Manufacturing Practices (cGMP) requirements necessitates a systematic approach to periodic review programs. These programs are crucial in ensuring that equipment and processes remain within validated…